161 related articles for article (PubMed ID: 3008055)
1. Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole.
Kim DS; Moon H; Kim KT; Moon YJ; Hwang YY
Obstet Gynecol; 1986 May; 67(5):690-4. PubMed ID: 3008055
[TBL] [Abstract][Full Text] [Related]
2. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
[TBL] [Abstract][Full Text] [Related]
3. Effects of prophylactic chemotherapy for postmolar trophoblastic disease in patients with complete hydatidiform mole.
Ayhan A; Ergeneli MH; Yüce K; Yapar EG; Kisnisci AH
Int J Gynaecol Obstet; 1990 May; 32(1):39-41. PubMed ID: 1971236
[TBL] [Abstract][Full Text] [Related]
4. Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?
Braga A; Torres B; Burlá M; Maestá I; Sun SY; Lin L; Madi JM; Uberti E; Viggiano M; Elias KM; Berkowitz RS
Gynecol Oncol; 2016 Dec; 143(3):558-564. PubMed ID: 27640962
[TBL] [Abstract][Full Text] [Related]
5. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
[TBL] [Abstract][Full Text] [Related]
6. Gestational trophoblastic disease following the evacuation of partial hydatidiform mole: a review of 66 cases.
Zalel Y; Dgani R
Eur J Obstet Gynecol Reprod Biol; 1997 Jan; 71(1):67-71. PubMed ID: 9031962
[TBL] [Abstract][Full Text] [Related]
7. Trophoblastic cell sensitivity to 8-day chemotherapy in nonmetastatic gestational trophoblastic neoplasia.
Hilgers RD; Standefer JC; Rutledge JM; Ampuero F
Gynecol Oncol; 1984 Mar; 17(3):386-93. PubMed ID: 6200387
[TBL] [Abstract][Full Text] [Related]
8. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic chemotherapy for hydatidiform mole. Five to 15 years follow-up.
Kashimura Y; Kashimura M; Sugimori H; Tsukamoto N; Matsuyama T; Matsukuma K; Kamura T; Saito T; Kawano H; Nose R
Cancer; 1986 Aug; 58(3):624-9. PubMed ID: 3015368
[TBL] [Abstract][Full Text] [Related]
10. Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen.
Dgani R; Zalel Y; Biran H; Blickstein I; Caspi B; Weissman A; Shoham Z
Eur J Obstet Gynecol Reprod Biol; 1994 Mar; 54(1):77-9. PubMed ID: 7519153
[TBL] [Abstract][Full Text] [Related]
11. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
12. Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancy.
Gillespie AM; Kumar S; Hancock BW
Br J Cancer; 2000 Apr; 82(8):1393-5. PubMed ID: 10780516
[TBL] [Abstract][Full Text] [Related]
13. Gestational trophoblastic disease following complete hydatidiform mole in Mulago Hospital, Kampala, Uganda.
Kaye DK
Afr Health Sci; 2002 Aug; 2(2):47-51. PubMed ID: 12789101
[TBL] [Abstract][Full Text] [Related]
14. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
15. Gestational trophoblastic disease.
Berkowitz RS; Goldstein DP
Cancer; 1995 Nov; 76(10 Suppl):2079-85. PubMed ID: 8635004
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
[TBL] [Abstract][Full Text] [Related]
17. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms.
Goldstein DP; Goldstein PR; Bottomley P; Osathanondh R; Marean AR
Obstet Gynecol; 1976 Sep; 48(3):321-3. PubMed ID: 181702
[TBL] [Abstract][Full Text] [Related]
19. The impact of uterine re-curettage, pre-evacuation and week-one level of hCG on the number of chemotherapy courses in treatment of post molar GTN.
Hemida RA; Toson E; Van Doorn HC
J Exp Ther Oncol; 2011; 9(3):217-20. PubMed ID: 22070053
[TBL] [Abstract][Full Text] [Related]
20. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
Lurain JR; Brewer JI
Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
